Precision medicine advances in idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a highly heterogeneous, unpredictable and ultimately lethal chronic lung disease. Over the last decade, two anti-fibrotic agents have been shown to slow disease progression, however, both drugs are administered uniformly with minimal consideration of disease se...

Descripción completa

Detalles Bibliográficos
Autores principales: Karampitsakos, Theodoros, Juan-Guardela, Brenda M., Tzouvelekis, Argyris, Herazo-Maya, Jose D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469771/
https://www.ncbi.nlm.nih.gov/pubmed/37625268
http://dx.doi.org/10.1016/j.ebiom.2023.104766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469771/
https://www.ncbi.nlm.nih.gov/pubmed/37625268
http://dx.doi.org/10.1016/j.ebiom.2023.104766

Ejemplares similares